Team | Year | Age | GS | G | IP | W | L | SV | BS | K | BB | H | HR | K% | BB% | HR% | LOB% | GB% | WHIP | BABIP | ERA | FIP | FIP- | xFIP | E-F | WAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Portsmouth - CPL (A)
PRT - CPL (A)
|
2054 | 23 | 2 | 26 | 54.2 | 3 | 2 | 0 | 0 | 74 | 16 | 49 | 11 | 32.5% | 7.02% | 4.8% | 76.5% | 47.6% | 1.19 | .312 | 4.61 | 4.28 | 107 | 2.99 | 0.33 | -0.01 |
Coco Cay - DRAKE
COC - DRAKE
|
2054 | 23 | 0 | 4 | 7.2 | 0 | 0 | 0 | 0 | 4 | 5 | 14 | 1 | 9.8% | 12.20% | 2.4% | 56.8% | 66.7% | 2.48 | .419 | 9.39 | 6.02 | 144 | 5.52 | 3.37 | -0.17 |
Portsmouth - CPL (A)
PRT - CPL (A)
|
2053 | 22 | 0 | 7 | 19.2 | 2 | 0 | 0 | 0 | 33 | 9 | 13 | 1 | 38.4% | 10.47% | 1.2% | 70.8% | 60.0% | 1.12 | .300 | 3.66 | 2.44 | 61 | 2.54 | 1.22 | 0.46 |
Coco Cay - DRAKE
COC - DRAKE
|
2052 | 21 | 5 | 17 | 45.0 | 1 | 7 | 1 | 1 | 50 | 28 | 42 | 5 | 23.8% | 13.33% | 2.4% | 64.3% | 54.3% | 1.56 | .311 | 5.60 | 4.89 | 114 | 4.72 | 0.71 | -0.06 |
Coco Cay - DRAKE
COC - DRAKE
|
2051 | 20 | 2 | 61 | 88.1 | 3 | 8 | 9 | 4 | 79 | 59 | 102 | 30 | 18.9% | 14.11% | 7.2% | 71.3% | 61.3% | 1.82 | .306 | 7.74 | 8.08 | 192 | 5.26 | -0.34 | -3.83 |
Coco Cay - DRAKE
COC - DRAKE
|
2050 | 19 | 3 | 36 | 65.0 | 1 | 3 | 1 | 2 | 76 | 54 | 81 | 12 | 23.2% | 16.46% | 3.7% | 69.5% | 50.5% | 2.08 | .386 | 6.37 | 6.84 | 133 | 5.61 | -0.47 | -0.88 |
Saylorville - SNL (R)
SAY - SNL (R)
|
2049 | 18 | 0 | 13 | 15.0 | 1 | 1 | 4 | 2 | 17 | 4 | 11 | 3 | 27.4% | 6.45% | 4.8% | 78.1% | 57.1% | 1.00 | .222 | 4.20 | 4.02 | 99 | 2.82 | 0.18 | 0.10 |
Saylorville - SNL (R)
SAY - SNL (R)
|
2048 | 17 | 0 | 29 | 30.1 | 1 | 4 | 13 | 3 | 27 | 17 | 30 | 4 | 20.0% | 12.59% | 3.0% | 80.2% | 57.6% | 1.55 | .302 | 3.86 | 3.98 | 110 | 3.59 | -0.12 | -0.00 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2048 | 17 | 8 | 8 | 38.1 | 2 | 2 | 0 | 0 | 55 | 12 | 28 | 4 | 35.3% | 7.69% | 2.6% | 63.2% | 48.3% | 1.04 | .289 | 3.99 | 2.25 | 54 | 2.97 | 1.74 | 1.53 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2047 | 16 | 0 | 15 | 15.1 | 0 | 1 | 9 | 0 | 23 | 11 | 12 | 2 | 33.8% | 16.18% | 2.9% | 89.1% | 52.4% | 1.50 | .313 | 2.35 | 3.54 | 81 | 3.58 | -1.19 | 0.27 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2046 | 15 | 0 | 17 | 24.0 | 0 | 0 | 0 | 1 | 26 | 30 | 37 | 3 | 18.8% | 21.74% | 2.2% | 66.9% | 52.5% | 2.79 | .460 | 9.00 | 7.31 | 130 | 7.96 | 1.69 | -0.29 |
Total - A
A
|
2 | 33 | 74.1 | 5 | 2 | 0 | 0 | 107 | 25 | 62 | 12 | 34.1% | 7.96% | 3.8% | 74.8% | 50.5% | 1.17 | .309 | 4.36 | 3.79 | 95 | 2.87 | 0.57 | 0.45 | ||
Total - S A
S A
|
10 | 118 | 206.0 | 5 | 18 | 11 | 7 | 209 | 146 | 239 | 48 | 21.0% | 14.64% | 4.8% | 68.5% | 56.9% | 1.87 | .339 | 6.90 | 6.92 | 155 | 5.26 | -0.01 | -4.94 | ||
Total - R
R
|
0 | 42 | 45.1 | 2 | 5 | 17 | 5 | 44 | 21 | 41 | 7 | 22.3% | 10.66% | 3.6% | 79.7% | 57.5% | 1.37 | .279 | 3.97 | 3.99 | 106 | 3.33 | -0.02 | 0.10 | ||
Total - HS
HS
|
8 | 40 | 77.2 | 2 | 3 | 9 | 1 | 104 | 53 | 77 | 9 | 28.7% | 14.64% | 2.5% | 69.4% | 50.4% | 1.67 | .360 | 5.21 | 4.07 | 83 | 4.63 | 1.15 | 1.51 | ||
Total - Minors
Minors
|
12 | 193 | 325.2 | 12 | 25 | 28 | 12 | 360 | 192 | 342 | 67 | 23.9% | 12.73% | 4.4% | 70.8% | 55.8% | 1.64 | .324 | 5.91 | 5.80 | 134 | 4.45 | 0.12 | -4.39 |